Skripsi
UJI ANTIDIABETES FRAKSI ETIL ASETAT DAUN PELAWAN (TRISTANIOPSIS MERGUENSIS GRIFF.) TERHADAP TIKUS JANTAN TERINDUKSI STREPTOZOTOSIN- DIET HIPERLIPIDEMIK DAN HISTOPATOLOGI PANKREAS
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by chronic hyperglycemia resulting from insulin resistance and pancreatic β-cell dysfunction. Pelawan leaves are known to contain bioactive compounds, particularly flavonoids and phenolics, which may exhibit antihyperglycemic activity. This study aimed to characterize the ethyl acetate fraction of pelawan leaves, evaluate the effects of its administration, observe pancreatic histopathological changes in T2DM-induced male rats, and determine the effective dose (ED₅₀) of the ethyl acetate fraction. Pelawan leaves were fractionated using a successive maceration method and characterized through phytochemical screening, specific and non-specific parameters, Total Phenolic Content (TPC), and Total Flavonoid Content (TFC) measured using a UV–Vis spectrophotometer. Diabetes was induced by a combination of a high-fat–fructose diet and streptozotocin at a dose of 35 mg/kg body weight. Observed parameters included fasting blood glucose levels, AUC₀–₁₅, percentage reduction of blood glucose levels (%PKGD), and pancreatic histopathology. Experimental animals were divided into treatment groups receiving the ethyl acetate fraction at doses of 40, 80, and 160 mg/kg body weight. The results showed that the ethyl acetate fraction of pelawan leaves met the extract characterization requirements according to the Indonesian Herbal Pharmacopoeia, with a TPC value of 32,04 ± 0,25 mg GAE/g and a TFC value of 19,79 ± 0,24 mg QE/g. Administration of the ethyl acetate fraction significantly reduced blood glucose levels, with effects increasing in a dose-dependent manner. Pancreatic histopathological observations revealed improvement in the structure of the islets of Langerhans, indicated by reduced β-cell damage and increased cell density in the highest-dose group. Based on these findings, the ethyl acetate fraction of pelawan leaves shows potential as an alternative antidiabetic candidate with antihyperglycemic activity and pancreatic protective effects, with an ED₅₀ value of 152,29 mg/kg body weight. Keywords: Ethyl acetate fraction, fenolic, pelawan leaves, type 2 diabetes mellitus.
No other version available